Search - Université de Rennes Access content directly

Filter your results

16 Results
authFullName_s : Valérie Ardisson

Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled microspheres.

Etienne Garin , Laurence Lenoir , Yan Rolland , Sophie Laffont , Marc Pracht et al.
Nuclear Medicine Communications, 2011, 32 (12), pp.1245-55. ⟨10.1097/MNM.0b013e32834a716b⟩
Journal articles hal-00739618v1

In Vitro Demonstration of Synergy/Additivity Between 188Rhenium and Sorafenib on Hepatoma Lines: Preliminary Results

Marc Pracht , Julien Edeline , Nicolas Lepareur , Laurence Lenoir , Valérie Ardisson et al.
Anticancer Research, 2013, 33 (9), pp.3871-3877
Journal articles hal-00934873v1

Occupational radiation exposure of medical staff performing (90)Y-loaded microsphere radioembolization

Sophie Laffont , Yan Rolland , Valérie Ardisson , Julien Edeline , Marc Pracht et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 (5), pp.824-831. ⟨10.1007/s00259-015-3277-1⟩
Journal articles hal-01255872v1

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization.

Laurence Lenoir , Julien Edeline , Yan Rolland , Marc Pracht , Jean-Luc Raoul et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 (5), pp.872-80. ⟨10.1007/s00259-011-2033-4⟩
Journal articles hal-00866999v1

Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity.

Stéphanie Becker , Nicolas Lepareur , Virginie Cadeillan , Valérie Ardisson , Sahar Bayat et al.
Cancer Biotherapy and Radiopharmaceuticals, 2012, 27 (2), pp.149-55. ⟨10.1089/cbr.2011.1072⟩
Journal articles hal-00867018v1

Therapy of hepatocellular carcinoma with Rhenium-188 Lipiodol

Nicolas Lepareur , Valérie Ardisson , Etienne Garin , Nicolas Noiret
current radiopharma, 2008, 1, pp.87-92
Journal articles hal-00403344v1
Image document

(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside.

Nicolas Lepareur , Valérie Ardisson , Nicolas Noiret , Etienne Garin
International Journal of Molecular Imaging, 2012, 2012, 278306 (9 p.). ⟨10.1155/2012/278306⟩
Journal articles hal-00866975v1

Automation of labelling of Lipiodol with high-activity generator-produced 188Re.

Nicolas Lepareur , Valérie Ardisson , Nicolas Noiret , Eveline Boucher , Jean-Luc Raoul et al.
Applied Radiation and Isotopes, 2011, 69 (2), pp.426-30. ⟨10.1016/j.apradiso.2010.11.001⟩
Journal articles istex hal-00752790v1
Image document

Re-188-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)

Etienne Garin , Xavier Palard-Novello , Yan Rolland , Samuel Le Sourd , Nicolas Lepareur et al.
Cancers, 2023, 15 (8), pp.2245. ⟨10.3390/cancers15082245⟩
Journal articles hal-04113561v1

First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation.

Etienne Garin , Yan Rolland , Eveline Boucher , Valérie Ardisson , Sophie Laffont et al.
European Journal of Nuclear Medicine, 2010, 37 (3), pp.453-61. ⟨10.1007/s00259-009-1279-6⟩
Journal articles istex hal-00742174v1

Composition for therapeutic use, including an organic lipid phase and a rare- earth radioisotope complex

Nicolas Lepareur , Etienne Garin , Nicolas Noiret , Valérie Ardisson
Patent n° : WO 2014012997. 2014, pp.25
Patents hal-00936709v1

Impact of tamoxifen and dexamethasone on membrane fluidity and tumor targeting of lipiodol in hepatocellular carcinoma

Stéphanie Becker , Nicolas Lepareur , Valérie Ardisson , Odile Sergent , Sahar Bayat et al.
Journal of Nuclear Medicine, 2010, 51 (Supplement 2), pp.1130
Journal articles hal-01117641v1

Therapeutic composition including an organic lipid phase and a complex of a rare earth radioisotope

Nicolas Lepareur , Etienne Garin , Nicolas Noiret , Valérie Ardisson
Patent n° : FR 2993462. 2014, pp.20
Patents hal-00936718v1

Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization

Kostas Delaunay , Julien Edeline , Yan Rolland , Nicolas Lepareur , Sophie Laffont et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 (7), pp.1506-1517. ⟨10.1007/s00259-019-04277-9⟩
Journal articles hal-03403456v1

Increased Lipiodol uptake in hepatocellular carcinoma possibly due to increased membrane fluidity by dexamethasone and tamoxifen.

Stéphanie Becker , Valérie Ardisson , Nicolas Lepareur , Odile Sergent , Sahar Bayat et al.
Nuclear Medicine and Biology, 2010, 37 (7), pp.777-84. ⟨10.1016/j.nucmedbio.2010.03.013⟩
Journal articles istex hal-00660227v1

Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.

Nicolas Lepareur , Sophie Laffont , Valérie Ardisson , Nicolas Noiret , Etienne Garin et al.
Nuclear Medicine Communications, 2012, 33 (2), pp.205-8. ⟨10.1097/MNM.0b013e32834e7580⟩
Journal articles hal-00867028v1